These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20601821)

  • 21. Peroxisome proliferator-activated receptor gamma is highly expressed in pancreatic cancer and is associated with shorter overall survival times.
    Kristiansen G; Jacob J; Buckendahl AC; Grützmann R; Alldinger I; Sipos B; Klöppel G; Bahra M; Langrehr JM; Neuhaus P; Dietel M; Pilarsky C
    Clin Cancer Res; 2006 Nov; 12(21):6444-51. PubMed ID: 17085658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of somatostatin in pancreatic ductal adenocarcinoma remodels the normal pattern of the protein during foetal pancreatic development: an immunohistochemical analysis.
    Tamiolakis D; Simopoulos C; Venizelos J; Lambropoulou M; Nikolaidou S; Tsikouras P; Koutsougeras G; Alexiadis G; Menegaki M; Papadopoulos N
    Clin Exp Med; 2005 Oct; 5(3):106-11. PubMed ID: 16284732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An unusual cause of pancreatitis--patient with dominant dorsal pancreatic duct syndrome and intraductal papillary mucinous neoplasm (IPMN) in the ventral pancreatic duct.
    Lee TC; Liu KL; Lin JT; Tien YW; Mao TL; Wang HP
    Gut; 2006 Feb; 55(2):164, 171. PubMed ID: 16407382
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immunohistochemical study of mucins in chronic pancreatitis and ductal adenocarcinoma of the pancreas].
    Paklina OV; Setdikova GR
    Arkh Patol; 2008; 70(4):13-7. PubMed ID: 18807519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A newly developed anti-Mucin 13 monoclonal antibody targets pancreatic ductal adenocarcinoma cells.
    Nishii Y; Yamaguchi M; Kimura Y; Hasegawa T; Aburatani H; Uchida H; Hirata K; Sakuma Y
    Int J Oncol; 2015 Apr; 46(4):1781-7. PubMed ID: 25672256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pancreatic cancer: a major challenge in oncology].
    Fölsch UR; Schäfer H
    Med Klin (Munich); 2004 Apr; 99(4):183-4. PubMed ID: 15085287
    [No Abstract]   [Full Text] [Related]  

  • 27. Thioredoxin is downstream of Smad7 in a pathway that promotes growth and suppresses cisplatin-induced apoptosis in pancreatic cancer.
    Arnold NB; Ketterer K; Kleeff J; Friess H; Büchler MW; Korc M
    Cancer Res; 2004 May; 64(10):3599-606. PubMed ID: 15150118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of N-nitrosobis(2-oxopropyl)amine-induced pancreatic carcinogenesis in hamsters by pioglitazone, a ligand of peroxisome proliferator-activated receptor gamma.
    Takeuchi Y; Takahashi M; Sakano K; Mutoh M; Niho N; Yamamoto M; Sato H; Sugimura T; Wakabayashi K
    Carcinogenesis; 2007 Aug; 28(8):1692-6. PubMed ID: 17449904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia-activated prodrugs in the treatment of advanced pancreatic adenocarcinoma.
    Babiker HM; Riaz IB; Shah SR; Von Hoff DD; Borad MJ
    Anticancer Drugs; 2017 Feb; 28(2):127-132. PubMed ID: 27685167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HER-2/Neu overexpression is a rare event in peri-ampullary cancer: assessment using the HercepTest.
    Aloysius MM; Lobo DN; Rowlands BJ; Madhusudan S; Ilyas M; Zaitoun AM
    Histopathology; 2009 Aug; 55(2):236-7. PubMed ID: 19694833
    [No Abstract]   [Full Text] [Related]  

  • 31. Amplification and overexpression of HER-2/neu in invasive ductal carcinomas of the pancreas and pancreatic intraepithelial neoplasms and the relationship to the expression of p21(WAF1/CIP1).
    Hermanová M; Lukás Z; Nenutil R; Brázdil J; Kroupová I; Kren L; Pazourková M; Růzicka M; Díte P
    Neoplasma; 2004; 51(2):77-83. PubMed ID: 15190415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraductal papillary mucinous neoplasm with invasive carcinoma in the setting of chronic alcoholic pancreatitis.
    Mackey R; Walsh RM
    Pancreas; 2007 May; 34(4):481-3. PubMed ID: 17446852
    [No Abstract]   [Full Text] [Related]  

  • 33. Ductal adenocarcinoma of the pancreas with psammomatous calcification. Report of a case.
    Ohike N; Sato M; Kawahara M; Ohyama S; Morohoshi T
    JOP; 2008 May; 9(3):335-8. PubMed ID: 18469450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic adenocarcinoma in a patient with Peutz-Jeghers syndrome: report of a case and literature review.
    Hirao S; Sho M; Kanehiro H; Hisanaga M; Ikeda N; Tsurui H; Nakajima Y; Nakano H
    Hepatogastroenterology; 2000; 47(34):1159-61. PubMed ID: 11020903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical detection of the beta4 integrin subunit in pancreatic adenocarcinoma.
    Gleason B; Adley B; Rao MS; Diaz LK
    J Histochem Cytochem; 2005 Jun; 53(6):799-801. PubMed ID: 15928331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The novel mitochondria-targeted antioxidant SkQ1 modulates angiogenesis and inflammatory micromilieu in a murine orthotopic model of pancreatic cancer.
    Bazhin AV; Yang Y; D'Haese JG; Werner J; Philippov PP; Karakhanova S
    Int J Cancer; 2016 Jul; 139(1):130-9. PubMed ID: 26914404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homeostatic restoration of desmoplastic stroma rather than its ablation slows pancreatic cancer progression.
    Froeling FE; Kocher HM
    Gastroenterology; 2015 Apr; 148(4):849-50. PubMed ID: 25724458
    [No Abstract]   [Full Text] [Related]  

  • 38. Irreversible electroporation: a novel pancreatic cancer therapy.
    Weiss MJ; Wolfgang CL
    Curr Probl Cancer; 2013; 37(5):262-5. PubMed ID: 24331180
    [No Abstract]   [Full Text] [Related]  

  • 39. Recapitulation of complex transport and action of drugs at the tumor microenvironment using tumor-microenvironment-on-chip.
    Han B; Qu C; Park K; Konieczny SF; Korc M
    Cancer Lett; 2016 Sep; 380(1):319-29. PubMed ID: 26688098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Proteome analysis--basis for individualized pancreatic carcinoma therapy?].
    Löhr JM; Faissner R; Findeisen P; Neumaier M
    Internist (Berl); 2006 Jun; 47 Suppl 1():S40-8. PubMed ID: 16773365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.